Is Online Compounded Semaglutide & Tirzepatide Safe? Complete Safety Guide

The Rise of Online GLP-1 Compounding

As demand for GLP-1 medications surged, registered compounding pharmacies stepped in to fill a critical gap. During declared drug shortages, policy permits 503A and 503B compounding facilities to produce these medications legally. This has opened the door to online telehealth providers offering compounded GLP-1s at a fraction of the brand-name cost — but not all services are equal. Understanding how to evaluate safety is essential.

Regulations: 503A vs 503B Pharmacies

The compounding pharmacy landscape is governed by two regulatory categories under the Drug Quality and Security Act (DQSA) of 2013. Understanding the difference is critical for evaluating any compounded medication provider.

• 503A pharmacies compound medications for specific, individual patients based on a valid prescription. They are regulated primarily by state pharmacy boards.
• 503B outsourcing facilities are federally registered facilities that can produce larger batches. They are required to follow Current Good Manufacturing Practice (cGMP) standards — the same standards applied to brand-name drug manufacturers.
• Cora partners exclusively with 503B-registered outsourcing facilities, ensuring every medication batch meets federal manufacturing standards before it ships.

Red Flags: What to Avoid

The rapid growth of online GLP-1 prescribing has attracted some operators who cut corners on safety. Watch for these warning signs when evaluating any telehealth weight loss provider:

• No licensed physician review — legitimate services require a real medical assessment before prescribing
• Pharmacy not registered as a 503B outsourcing facility
• No Certificate of Analysis (COA) available upon request — COAs confirm potency, purity, and sterility testing results
• Prices dramatically below market rate (often a sign of substandard manufacturing)
• No 24/7 or ongoing provider support after prescription is issued
• No mention of cold-chain shipping — GLP-1 peptides are temperature-sensitive
• Offering to prescribe without any health history or questionnaire
• Vague or missing information about the compounding pharmacy being used

How Cora Ensures Medication Quality

Cora's safety infrastructure is built around one principle: every patient receives medication that meets the same quality standards they would expect from a hospital-dispensed drug.

• All medications are sourced from 503B registered outsourcing facilities
• Every batch undergoes third-party potency testing (HPLC methodology) to confirm active ingredient concentration
• Sterility testing follows USP <71> protocols — the same standards used for injectable pharmaceuticals
• Endotoxin (pyrogen) testing is conducted on every lot using Limulus Amebocyte Lysate (LAL) testing
• Cold-chain shipping with insulated packaging and temperature indicators — medications arrive safely refrigerated
• Certificates of Analysis are available to all patients upon request

The Physician Review Process

Every Cora patient undergoes a comprehensive medical assessment reviewed by a licensed, board-certified physician — not a nurse practitioner or automated algorithm. Providers evaluate your health history, current medications, BMI, comorbidities, and contraindications before issuing any prescription. This is not a formality; it is a medical necessity. GLP-1 medications are prescription drugs with real risks for certain populations, and proper physician oversight is non-negotiable.

Questions to Ask Any GLP-1 Provider

Before starting compounded semaglutide or tirzepatide with any telehealth service, ask these questions:

• Which pharmacy compiles my medication — is it 503A or 503B registered?
• Can I see the Certificate of Analysis for my medication lot?
• What board-certified physicians review patient assessments?
• How does the pharmacy test for potency and sterility?
• What is your cold-chain shipping process?
• What ongoing provider support is available after I start treatment?
• What is your process if I experience a serious side effect?